Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Animal Model Market Growth From $2.24 Billion In 2026 To $2.97 Billion By 2030 At A CAGR Of 7.3%
The animal model market size has shown significant expansion in recent years. It is anticipated to expand from $2.07 billion in 2025 to $2.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. The historical growth in this market was largely driven by factors including the increasing incidence of chronic diseases, a greater demand for preclinical research, growth within pharmaceutical R&D, technological improvements in laboratory equipment, and the expansion of academic research institutions.
The animal model market is anticipated to show significant expansion in the upcoming years. It is projected to achieve a value of $2.97 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3%. The growth observed during this forecast period is attributable to several factors, including the adoption of AI and machine learning in preclinical studies, the rise of precision medicine initiatives, the growth of CROs and outsourcing, the expansion of genetically modified animal models, and an increased focus on translational research. Key trends for the forecast period include the development of advanced animal models, the increasing use of genetically engineered models, the application of high-throughput screening in preclinical studies, the integration of imaging and diagnostic tools, and the expansion of contract research organizations.
Get A Free Sample Report With In-Depth Market Insights:
Animal Model Market Demand Drivers Opening New Revenue Streams
The escalating investment in pharmaceutical research and development (R&D) is projected to stimulate the growth of the animal model market. This pharmaceutical R&D process involves the discovery, development, and assessment of new therapeutic approaches, requiring extensive preclinical studies to ascertain their safety, efficacy, and underlying biological mechanisms before progressing to human trials. The increase in R&D spending is largely attributed to the rising demand for innovative treatments, the expanding prevalence of complex illnesses, and continuous advancements in scientific understanding. Animal models play an indispensable role in this sequence by providing reliable preclinical environments that mirror human physiology, allowing for a predictive evaluation of drug performance. For example, in November 2023, a report issued by the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade group, revealed that pharmaceutical industry research and development expenditure surged to 50,000 million in 2023, an increase from 47,010 million in 2022. Therefore, the growing pharmaceutical R&D expenditure is a primary driver for the expansion of the animal model market.
Animal Model Market Segment Performance And Emerging Opportunities
The animal model market covered in this report is segmented –
1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations
Subsegments:
1) By Mice: Inbred Mice, Outbred Mice, Knockout Mice, Transgenic Mice
2) By Rat: Inbred Rats, Outbred Rats, Transgenic Rats, Knockout Rats
3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs
4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds
5) By Hamsters: Syrian Hamsters, Chinese Hamsters
6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)
Animal Model Market Trends Powering Strategic Industry Growth
Leading companies in the animal model sector are concentrating on creating advanced products like triple-immunodeficient animal models. This effort aims to improve the precision and dependability of preclinical investigations, foster sophisticated biomedical research, and accelerate the discovery of new treatments for intricate human ailments. These models, usually mice, are specifically designed animals missing three vital immune system elements. They prove extremely valuable in biomedical research, especially for investigating human illnesses and innovating new therapies. An example is the launch of NCG mouse strains by Charles River Laboratories International, Inc., a US-based pharmaceutical company, in January 2024. These are triple-immunodeficient mouse models intended for oncology research. NCG mice possess triple immunodeficiency, meaning they lack functional or mature T, B, and NK cells, and also show diminished macrophage and dendritic cell functionality. Such animal models are capable of supporting xenograft cells, tissues, and human immune system components. This specific mouse model is perfectly suited for studies across oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant investigations. Furthermore, NCG mice can be used to generate humanized mice through the engraftment of PBMCs or CD34+ stem cells, thereby closely replicating the human immune system.
Animal Model Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.
View The Full Animal Model Market Report:
Animal Model Market Top Region By Revenue And Market Share
North America was the largest region in the animal model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
